YJH-012

N/A

Report date: 2025/09/11 17:25:03
NME

Base Information

Drug NameYJH-012
Drug Alias NameYJH-012YJH012LZHN2408
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperuricemiaGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLivzon Pharmaceutical Group Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLivzon Pharmaceutical Group Inc
Inactive CompaniesN/A
Active IndicationsHyperuricemiaGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A